Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
CMRAW was delisted on the 15th of November, 2023.
22 hedge funds and large institutions have $630K invested in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$33.1K |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$25.1K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$25K |
| 4 |
TCM
Tenor Capital Management
New York
|
+$24.6K |
| 5 |
AC
Ayrton Capital
Westport,
Connecticut
|
+$16.4K |
Top Sellers
CMRAW Hedge Fund Activity: Q2 2022 in Review
22 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) for Q2 2022, worth a combined $630K.
Buyers outnumbered sellers: 22 funds opened new CMRAW positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Warberg Asset Management, opening a new position worth an estimated $33.1K.
- 22 institutional investors held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) as of Q2 2022, up from 0 in Q1 2022.
- Funds reported $630K of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 stock for Q2 2022.
- 22 funds opened new Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 positions in Q2 2022 and 0 closed out, a net change of +22 holders.
- The largest Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 buyer in Q2 2022 was Warberg Asset Management, an estimated $33.1K added.
Based on aggregated 13F filings for Q2 2022.